Essential medicines for chronic respiratory diseases: can people breathe easily in low-income countries?

Affiliations

¹ Department of Research, International Union Against Tuberculosis and Lung Disease (The Union), School of Population Health, University of Auckland, Auckland, New Zealand. kbissell@theunion.org.

Editorial

Karen Bissell. Int J Tuberc Lung Dis. 2015 Jan.

. 2015 Jan;19(1):1.

doi: 10.5588/ijtld.14.0862.

¹ Department of Research, International Union Against Tuberculosis and Lung Disease (The Union), School of Population Health, University of Auckland, Auckland, New Zealand. kbissell@theunion.org.

No abstract available

Comment on

The global burden of chronic respiratory disease in adults.
Burney P, Jarvis D, Perez-Padilla R. Burney P, et al. Int J Tuberc Lung Dis. 2015 Jan;19(1):10-20. doi: 10.5588/ijtld.14.0446. Int J Tuberc Lung Dis. 2015. PMID: 25519785 Review.
Gaps in using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites.
Gnatiuc L, Buist AS, Kato B, Janson C, Aït-Khaled N, Nielsen R, Koul PA, Nizankowska-Mogilnicka E, Obaseki D, Idolor LF, Harrabi I, Burney PG; BOLD Collaboration. Gnatiuc L, et al. Int J Tuberc Lung Dis. 2015 Jan;19(1):21-30. doi: 10.5588/ijtld.14.0263. Int J Tuberc Lung Dis. 2015. PMID: 25519786 Free PMC article.